<DOC>
	<DOCNO>NCT03016325</DOCNO>
	<brief_summary>A Study Evaluate Safety Efficacy Continuous 48-Hour Intravenous Infusions HNO Donor Hospitalized Patients Heart Failure Impaired Systolic Function</brief_summary>
	<brief_title>Evaluate Safety Efficacy 48-Hour Infusions HNO ( Nitroxyl ) Donor Hospitalized Patients With Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>For information regard BristolMyers Squibb Clinical Trial participation , please visit www.BMSStudyConnect.com Actively hospitalize acute decompensated heart failure At least 1 administration IV diuretic current episode Be randomize within 18 hour first dose IV diuretic current episode Have shortness breath rest minimal exertion administration 1 dose IV diuretic Have history heart failure leave ventricular ejection fraction ( LVEF ) â‰¤ 40 % Systolic blood pressure &lt; 105mm Hg &gt; 160mm Hg heart rate &lt; 50 &gt; 130 bpm Have active infection require IV antimicrobial treatment Severe lung disease may interfere assessment ( e.g. , severe chronic obstructive pulmonary disease , active asthma acute pneumonia ) Be hospitalize acute coronary syndrome , coronary revascularization acute myocardial infarction previous 90 day prior screen Have history cerebral vascular accident ( CVA stroke ) transient ischemic attack ( TIA ) previous 90 day prior screen Other protocol define inclusion/exclusion criterion could apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>